Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Augmented
AMP-activated protein kinase
(
AMPK
) activity inhibits cell migration, possibly contributing to the clinical benefits of chemical
AMPK
activators in preventing atherosclerosis, vascular remodelling and cancer metastasis. However, the underlying mechanisms remain largely unknown. Here we identify
PDZ and LIM domain 5
(Pdlim5) as a novel
AMPK
substrate and show that it plays a critical role in the inhibition of cell migration.
AMPK
directly phosphorylates Pdlim5 at Ser177. Exogenous expression of phosphomimetic S177D-Pdlim5 inhibits cell migration and attenuates lamellipodia formation. Consistent with this observation, S177D-Pdlim5 suppresses Rac1 activity at the cell periphery and displaces the Arp2/3 complex from the leading edge. Notably, S177D-Pdlim5, but not WT-Pdlim5, attenuates the association with Rac1-specific guanine nucleotide exchange factors at the cell periphery. Taken together, our findings indicate that phosphorylation of Pdlim5 on Ser177 by
AMPK
mediates inhibition of cell migration by suppressing the Rac1-Arp2/3 signalling pathway.
...
PMID:Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5. 2563 15
PDZ and LIM domain 5
(
PDLIM5
) is a cytoskeleton-associated protein and has been shown to bind to a variety of proteins through its specific domain, thereby acting to regulate cell migration and tumor progression. Here, we found that
PDLIM5
was abnormally upregulated in prostate cancer (PCa) tissues as compared with that in normal prostate tissue. ONCOMINE microarray data mining showed that
PDLIM5
was closely correlated with the prognosis of PCa in terms of Gleason score, tumor metastasis and biochemical recurrence. Lentivirus-mediated short hairpin RNA (shRNA) knockdown of
PDLIM5
inhibited cell proliferation and colony formation, arrested hormone independent PCa cells DU145 and PC-3 in G2/M phase, and induced apoptosis. Meanwhile, silencing
PDLIM5
inhibited migration and invasion of tumor cells by reversing the mesenchymal phenotype and a similar result was confirmed in a xenograft nude mouse model. Finally, we found
PDLIM5
plays a crucial role in regulating malignant tumor cell proliferation, invasion and migration by binding to
AMPK
and affecting its activation and degradation, and may therefore prove to be a potential oncogenic gene in the development and progression of PCa.
...
PMID:High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer. 2922 78